TrialBlood advances2026

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Ananth Shankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.